51 articles, transcripts, and reports
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2025 earnings results today. Revenues dipped 1% year-over-year to $17.6 billion. On an operational basis, revenues were…
Pfizer inc (NYSE: PFE) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Francesca DeMartino — Chief Investor Relations Officer, Senior Vice President Albert…
Pfizer inc (NYSE: PFE) Q3 2025 Earnings Call dated Nov. 04, 2025 Corporate Participants: Francesca DeMartino — Chief Investor Relations Officer and Senior Vice President…
Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third quarter 2025 earnings results. The…
Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income decreased 5% to…
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved…
Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday, despite the company delivering better-than-expected earnings results for the third quarter of 2024,…
Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today. Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally. Reported net…
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results. Although the top…
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1…
